Market OverviewThe Global Carrier Screening Market is a genetic testing process that determines whether an individual carries ...

Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare ...

The prognostic test stratifies hospitalized women with hypertensive disorders of pregnancy into low- and high-risk categories for developing severe preeclampsia.

Companion Diagnostics Market Companion Diagnostics Market Dublin, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The "Companion ...

Introduction Blood cancer diagnostics refers to the process of detecting and identifying cancers that affect the blood, bone marrow, and lympha ...

Illumina is part of the Health Care sector, which has an average P/E ratio of 26.07 and an average P/B of 3.53 The company ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

The global nucleic acid testing market is witnessing unprecedented growth, with a market size of USD 3.7 billion in 2023, driven by a robust compound annual growth rate (CAGR) of 6.8%. By the end of ...

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

New Delhi: Drug regulator Central Drugs Standard Control Organization (CDSCO) and the Indian Council of Medical Research (ICMR) are firming up standard evaluation and quality protocols for Human ...